Weatherman2020
Diamond Member
It’s not negligence. Deep State guaranteed nobody can be sued so they just don’t care. The money is pouring in and it’s all about keeping the gravy train going. Children are fodder to them, who cares they are being killed?
“The fact the US, CDC, NIAID, FDA, etc etc. have to rely on a Thailand preprint for the first prospective study of cardiac biomarkers is mind-boggling negligence. The US and this CDC have shown that either they are incompetent to take safety signals seriously, or indifferent to safety. They earn Grade F. This study should have been done in the USA, by Pfizer 1 month after EUA was granted. End of story.”
“In keeping with the FDA’s tradition of being lax, the agency gave Pfizer till 2022 and 2024 to provide these data. That’s pretty shitty for a live problem that affects millions of boys, where the information can be generated in 1 month by a company shoveling billions into its pockets.”
“I will get right to the point. The authors ran a bunch of tests on kids (202 boys, 99 girls) aged 13-18 who got the 2nd dose of Pfizer, after getting the first dose without adverse events. The EKG changes in the pre-print are not the story. The story are rates of cardiac biomarkers and how often they are elevated. 3 patients had chest pain and biomarker elevation; 4 patients had no chest pain but elevated cardiac biomarkers. These were all in boys.
7/202 boys had overt or subclinical myocarditis (3.5%) or roughly 2 orders of magnitude more common than prior reports from passive adverse event reporting of myocarditis.”
vinayprasadmdmph.substack.com
“The fact the US, CDC, NIAID, FDA, etc etc. have to rely on a Thailand preprint for the first prospective study of cardiac biomarkers is mind-boggling negligence. The US and this CDC have shown that either they are incompetent to take safety signals seriously, or indifferent to safety. They earn Grade F. This study should have been done in the USA, by Pfizer 1 month after EUA was granted. End of story.”
“In keeping with the FDA’s tradition of being lax, the agency gave Pfizer till 2022 and 2024 to provide these data. That’s pretty shitty for a live problem that affects millions of boys, where the information can be generated in 1 month by a company shoveling billions into its pockets.”
“I will get right to the point. The authors ran a bunch of tests on kids (202 boys, 99 girls) aged 13-18 who got the 2nd dose of Pfizer, after getting the first dose without adverse events. The EKG changes in the pre-print are not the story. The story are rates of cardiac biomarkers and how often they are elevated. 3 patients had chest pain and biomarker elevation; 4 patients had no chest pain but elevated cardiac biomarkers. These were all in boys.
7/202 boys had overt or subclinical myocarditis (3.5%) or roughly 2 orders of magnitude more common than prior reports from passive adverse event reporting of myocarditis.”
What does the Thailand Myocarditis Study Teach Us?
Taking safety signals seriously is imperative; the US CDC & others have failed to do that
vinayprasadmdmph.substack.com
